371 related articles for article (PubMed ID: 9724521)
1. Highly selective mechanism-based thrombin inhibitors: structures of thrombin and trypsin inhibited with rigid peptidyl aldehydes.
Krishnan R; Zhang E; Hakansson K; Arni RK; Tulinsky A; Lim-Wilby MS; Levy OE; Semple JE; Brunck TK
Biochemistry; 1998 Sep; 37(35):12094-103. PubMed ID: 9724521
[TBL] [Abstract][Full Text] [Related]
2. A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site.
Katz BA; Elrod K; Luong C; Rice MJ; Mackman RL; Sprengeler PA; Spencer J; Hataye J; Janc J; Link J; Litvak J; Rai R; Rice K; Sideris S; Verner E; Young W
J Mol Biol; 2001 Apr; 307(5):1451-86. PubMed ID: 11292354
[TBL] [Abstract][Full Text] [Related]
3. Molecular design and characterization of an alpha-thrombin inhibitor containing a novel P1 moiety.
Malikayil JA; Burkhart JP; Schreuder HA; Broersma RJ; Tardif C; Kutcher LW; Mehdi S; Schatzman GL; Neises B; Peet NP
Biochemistry; 1997 Feb; 36(5):1034-40. PubMed ID: 9033393
[TBL] [Abstract][Full Text] [Related]
4. In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug design.
Costanzo MJ; Almond HR; Hecker LR; Schott MR; Yabut SC; Zhang HC; Andrade-Gordon P; Corcoran TW; Giardino EC; Kauffman JA; Lewis JM; de Garavilla L; Haertlein BJ; Maryanoff BE
J Med Chem; 2005 Mar; 48(6):1984-2008. PubMed ID: 15771442
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the structures of the cyclotheonamide A complexes of human alpha-thrombin and bovine beta-trypsin.
Ganesh V; Lee AY; Clardy J; Tulinsky A
Protein Sci; 1996 May; 5(5):825-35. PubMed ID: 8732754
[TBL] [Abstract][Full Text] [Related]
6. Factorising ligand affinity: a combined thermodynamic and crystallographic study of trypsin and thrombin inhibition.
Dullweber F; Stubbs MT; Musil D; Stürzebecher J; Klebe G
J Mol Biol; 2001 Oct; 313(3):593-614. PubMed ID: 11676542
[TBL] [Abstract][Full Text] [Related]
7. Think twice: understanding the high potency of bis(phenyl)methane inhibitors of thrombin.
Baum B; Muley L; Heine A; Smolinski M; Hangauer D; Klebe G
J Mol Biol; 2009 Aug; 391(3):552-64. PubMed ID: 19520086
[TBL] [Abstract][Full Text] [Related]
8. Human alpha-thrombin inhibition by the active site titrant N alpha-(N,N-dimethylcarbamoyl)-alpha-azalysine p-nitrophenyl ester: a comparative kinetic and X-ray crystallographic study.
Nardini M; Pesce A; Rizzi M; Casale E; Ferraccioli R; Balliano G; Milla P; Ascenzi P; Bolognesi M
J Mol Biol; 1996 May; 258(5):851-9. PubMed ID: 8637015
[TBL] [Abstract][Full Text] [Related]
9. Discovery of benzothiazole guanidines as novel inhibitors of thrombin and trypsin IV.
Karle M; Knecht W; Xue Y
Bioorg Med Chem Lett; 2012 Jul; 22(14):4839-43. PubMed ID: 22726924
[TBL] [Abstract][Full Text] [Related]
10. Peptidyl beta-homo-aspartals (3-amino-4-carboxybutyraldehydes): new specific inhibitors of caspases.
Bajusz S; Fauszt I; Németh K; Barabás E; Juhász A; Patthy M; Bauer PI
Biopolymers; 1999; 51(1):109-18. PubMed ID: 10380358
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of trypsin and thrombin by amino(4-amidinophenyl)methanephosphonate diphenyl ester derivatives: X-ray structures and molecular models.
Bertrand JA; Oleksyszyn J; Kam CM; Boduszek B; Presnell S; Plaskon RR; Suddath FL; Powers JC; Williams LD
Biochemistry; 1996 Mar; 35(10):3147-55. PubMed ID: 8605148
[TBL] [Abstract][Full Text] [Related]
12. Enzyme binding selectivity prediction: alpha-thrombin vs trypsin inhibition.
Mlinsek G; Novic M; Kotnik M; Solmajer T
J Chem Inf Comput Sci; 2004; 44(5):1872-82. PubMed ID: 15446847
[TBL] [Abstract][Full Text] [Related]
13. S1 subsite in snake venom thrombin-like enzymes: can S1 subsite lipophilicity be used to sort binding affinities of trypsin-like enzymes to small-molecule inhibitors?
Silva FP; De-Simone SG
Bioorg Med Chem; 2004 May; 12(10):2571-87. PubMed ID: 15110839
[TBL] [Abstract][Full Text] [Related]
14. Comparative binding energy analysis considering multiple receptors: a step toward 3D-QSAR models for multiple targets.
Murcia M; Morreale A; Ortiz AR
J Med Chem; 2006 Oct; 49(21):6241-53. PubMed ID: 17034130
[TBL] [Abstract][Full Text] [Related]
15. From natural products to achiral drug prototypes: potent thrombin inhibitors based on P2/P3 dihydropyrid-2-one core motifs.
Hanessian S; Therrien E; Zhang J; Otterlo Wv; Xue Y; Gustafsson D; Nilsson I; Fjellström O
Bioorg Med Chem Lett; 2009 Sep; 19(18):5429-32. PubMed ID: 19674897
[TBL] [Abstract][Full Text] [Related]
16. Recruiting Zn2+ to mediate potent, specific inhibition of serine proteases.
Katz BA; Luong C
J Mol Biol; 1999 Sep; 292(3):669-84. PubMed ID: 10497030
[TBL] [Abstract][Full Text] [Related]
17. Rational design, synthesis, and X-ray structure of selective noncovalent thrombin inhibitors.
Wagner J; Kallen J; Ehrhardt C; Evenou JP; Wagner D
J Med Chem; 1998 Sep; 41(19):3664-74. PubMed ID: 9733491
[TBL] [Abstract][Full Text] [Related]
18. Crystal structures of thrombin complexed to a novel series of synthetic inhibitors containing a 5,5-trans-lactone template.
Jhoti H; Cleasby A; Reid S; Thomas PJ; Weir M; Wonacott A
Biochemistry; 1999 Jun; 38(25):7969-77. PubMed ID: 10387040
[TBL] [Abstract][Full Text] [Related]
19. Oxyanion-mediated inhibition of serine proteases.
Presnell SR; Patil GS; Mura C; Jude KM; Conley JM; Bertrand JA; Kam CM; Powers JC; Williams LD
Biochemistry; 1998 Dec; 37(48):17068-81. PubMed ID: 9836602
[TBL] [Abstract][Full Text] [Related]
20. High-resolution structures of three new trypsin-squash-inhibitor complexes: a detailed comparison with other trypsins and their complexes.
Helland R; Berglund GI; Otlewski J; Apostoluk W; Andersen OA; Willassen NP; Smalås AO
Acta Crystallogr D Biol Crystallogr; 1999 Jan; 55(Pt 1):139-48. PubMed ID: 10089404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]